Skip to main content
. 2018 Sep 27;36:196–208. doi: 10.1016/j.ebiom.2018.09.034

Fig. 1.

Fig. 1

SNF-CC identifies two robust subsets of KRAS-mutant lung adenocarcinomas in patients and cell lines.

(a) SNF-CC integrated 5 data types of patients and similarity matrices for each class.

(b) Silhouette values for the k = 2 to k = 5 classes.

(c) The percentages of important features (top 20% NMI) from each data type that contribute to the fused network.

(d) SNF-CC integrated 3 data types of cell lines (N = 28) and similarity matrices for each class.